ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Data reviewed in this article demonstrate that both interferon-ß-1a (IFNß-1a) and interferon-ß-1b (IFNß-1b) show a dose-response relationship in multiple sclerosis at current clinical doses. Moreover, ...

A new paper from the University of Kansas overturns the idea that a "risk gene" carried by millions of people worldwide ...

SAN FRANCISCO -- A company hoping to market an inhalable formulation of interferon beta for viral lung diseases isn't dissuaded by phase III trial results in 623 hospitalized COVID-19 patients, which ...

September 25, 2012 (Vienna, Austria) — There is still no cure for the common cold, but interferon-β significantly decreases the frequency of cold-induced exacerbations in people with ...

A new paper from the University of Kansas overturns the idea that a "risk gene" carried by millions of people worldwide ...

DUBLIN--(BUSINESS WIRE)--The "Interferon - Biosimilar Insight, 2020" report has been added to ResearchAndMarkets.com's offering. This Interferon-Biosimilar Insight, 2020 report provides comprehensive ...

The Covid-19 pandemic is characterized by successive waves of infection driven by variants that have evolved to become more transmissible and immune evasive. Much of the attention has focused on ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 76, No. 10 (Oct., 1979), pp. 4778-4782 (5 pages) Among the mediators of interferon action are one enzyme that is ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...